Speakers 2020

Professor Egbert Herting

Egbert Herting is a Professor in Paediatrics and Director of the University Children’s Hospital in Lübeck, Germany. He studied medicine in Münster, Germany and Cardiff, Wales, UK and graduated in 1984.He started his professional career in the Paediatric District Hospital of Minden, Westphalia, Germany before he became a research fellow at Göttingen University in Northern Germany in 1985. From 1992 to 1994 he received a grant from the German Research Foundation (DFG) and worked as a research fellow with Prof. Bengt Robertson, one of the pioneers in surfactant research, at the Karolinska Institute, Stockholm, Sweden.

His main fields of research interest are surfactant deficiency and neonatal pulmonary and infectious disease. His work on single versus multiple doses of porcine surfactant (MD) and surfactant for secondary respiratory distress syndrome. He is the author of various research and book articles especially on the topics of neonatal pulmonary disease, surfactant replacement therapy, and neonatal infections.


In the last 15 years his clinical research interest was focused on less invasive surfactant administration (LISA). He is a member in various national and international societies, past president of the German Association for Neonatology and Pediatric Intensive Care (GNPI), and congress president/council member the German Society for Pediatrics (DGKJ). Currently, he is an advisor for the German Research Council (DFG).

  Dr. Beatrisj van der Hout

Beatrijs van der Hout is medical engineer in the Fundamental Perinatology research group of Prof. Guid Oei. The research aims at reducing maternal and perinatal morbidity and mortality rates through mathematical modeling & simulation, simulation-based education, and electrophysiological pregnancy monitoring. This research is part of research area Perinatal Medicine of Eindhoven MedTech Innovation Center (e/MTIC). The group launcehd the ambitious ‘Artificial Womb’ project after recieiving a grant 2.9million Euro from the European Union that promises to transform the care of extreme prematurity.

M. Beatrijs van der Hout-van der Jagt obtained her BSc. degree in Midwifery from Artevelde University College, Ghent, Belgium in 2002. She continued her education at Eindhoven University of Technology, and received her BSc. and MSc. degree in (Bio)Medical Engineering in 2005 and 2007 respectively, and her Qualified Medical Engineering certificate in 2010, and PhD at dep. of Electrical Engineering in 2013. Since 2005, she is involved in perinatal research projects in collaboration with Máxima Medical Center and Eindhoven University of Technology (research groups Cardiovascular BioMechanics and Signal Processing Systems). Since 2014 she is actively involved in the daily management team of Perinatal Medicine, one of the three research areas of e/MTIC (Eindhoven MedTech Innovation Center).

  Dr. Anita Banerjee

Anita Banerjee is a consultant obstetric physician, diabetes and endocrinology consultant, acute physician and honorary senior lecturer at King’s College London.


As an educationalist Anita teaches on all aspects of medical problems in pregnancy at local, national and international meetings. She leads the high-fidelity simulation training for the deteriorating pregnant patient at St Thomas’ Hospital. She has been involved in writing the curriculum for the special skills module in obstetric medicine for acute medicine and the e-learning module for medical problems in pregnancy.


Anita is a member of the OAA sub-group committee for the deteriorating pregnant patient and leads on the obstetric acute kidney injury pathway in London. She is also a member of several committees including; UKOSS steering committee, MBRRACE assessor and SCLN London morbidity and mortality committee.

  Professor Ola Andersson

Ola Andersson is a consultant neonatologist at Skåne University Hospital and is the medical director at the Research and Development department. He is also affiliated to Uppsala University in Sweden. His research into the advantages of delayed cord clamping of newborns has had global impact and changed the guidelines and procedures in obstetrics the world over. He is the recipient of the 2019 prestigious Hugo Lagercrantz national award in Sweden

  Cath Broderick

Cath is an independent consultant working in healthcare. She is an Honorary Fellow of the Royal College of Obstetricians and Gynaecologists (RCOG), was Chair of the RCOG Women’s Network from 2011-2015 and has been involved with the RCOG’s patient and public engagement activities since 2007. She is now Chair of the RCOG Equality and Diversity Committee.

She has worked extensively in the field of patient and public engagement and large scale, complex consultation for NHS reconfiguration. She has also work for national projects including the consultation on the reconfiguration of health services for children and young people, maternity services and neonatal intensive care in Greater Manchester.

As a member of the Independent Reconfiguration Panel until 2017 she was involved in many reviews regarding contested reconfiguration proposals across the country. She has worked with many NHS organisations to build understanding of the needs for effective engagement in service change

  Professor Neil Marlow

Neil Marlow is Professor of Neonatal Medicine at University College London and current Chair of the NHS England Neonatal Critical Care Clinical Reference Group. He took up this appointment at UCL following 11 years as Professor of Neonatal Medicine at Nottingham and 7 years as Senior Lecturer in Bristol. He is an Honorary Consultant in the University College Hospital Neonatal Service.

His major academic interests have been in long-term outcomes following prematurity and he is the Director of the MRC-funded EPICure studies. He runs a series of local studies into brain and cognitive development following very preterm birth and is a co-investigator on a range of mainly UK based cohort and randomised studies.

Neil has been President of the British Association for Perinatal Medicine, Director of the UCL Institute for Women’s Health, President of the European Society for Paediatric Research and Chair of two European Academy of Paediatric Societies Meetings. He was elected a Fellow of the Academy of Medical Sciences and is an Honorary Life Friend of Bliss, the UK-based charity for premature babies. He has recently been appointed to the executive of the European Foundation for the Care of Newborn Infants.

  Professor Mary Rutherford

Mary Rutherford is a Professor of Perinatal Imaging at King’s College, London. Mary trained as a paediatrician, specialising in neonatal neurology. She has worked with magnetic resonance imaging (MRI) for over 30 years. Her expertise is in the acquisition and interpretation of fetal and neonatal MRI of the brain. Her research interests include optimising MR sequences to allow objective quantification of both normal and abnormal brain development.


She is employed by Kings College London and has an Honorary contract with Guys and St Thomas’ Trust (GSTT). She also holds an honorary post in the Department of Paediatrics, University of Stellenbosch, South Africa.

  Professor Geraldine Boylan

Geraldine Boylan is Professor of Neonatal Physiology at UCC and is the Director of the INFANT research centre www.infantcentre.ie

Geraldine has worked in the area of clinical neurophysiology for many years and since 1996 has worked exclusively in the field of neonatal neurophysiology. She has been a Science Foundation Ireland Principal Investigator since 2006. Geraldine leads the Neonatal Brain Research Group at the INFANT centre – a multidisciplinary research team focused on neurological monitoring of infants in the neonatal intensive care unit, particularly for seizure detection and the early diagnosis of brain injury. Researchers in the team develop automated algorithms for monitoring brain activity and monitoring tools for physiological data acquisition. They developed a seizure detection algorithm for newborn infants and a Wellcome Trust funded clinical trial evaluating the clinical efficacy of this algorithm has just been completed in 8 centres across Europe www.anserstudy.com. Geraldine was also the co-coordinator of the EU funded NEMO study, Europe’s first multicentred dose finding and safety study of bumetanide for the treatment of seizures in newborn infants http://www.nemo-europe.com

Geraldine is Director of the Irish Centre for Fetal and Translational Research’ (INFANT) was established in 2013 under the Science Foundation Ireland (SFI) Research Centre Programme and is Ireland’s only perinatal translational research Centre. INFANT’s mission is to meet the urgent unmet clinical need for screening tests, diagnostics, therapeutics and devices for the early identification, diagnosis and effective treatment of perinatal complications and associated adverse outcomes in pregnancy, birth and the neonatal period. The overarching vision of INFANT is to advance perinatal translational research and to place Ireland to the forefront of this field.
INFANT is hosted by University College Cork (UCC) in partnership with RCSI, NUI Galway and TCD. Since 2013, INFANT has grown to be over a 100-person Research Centre with partners in 25 countries and collaborating with over 20 industry partners. INFANT is focused on delivering scientific excellence and impact through a range of activities in academic, translational and commercial areas. The INFANT team is a diverse group of clinicians and scientists who are supported by selected industry partners, international collaborators and business and regulatory advisors. The Centre is core funded by SFI and supported by other national and international funding agencies, EU, industry and philanthropy.